126 related articles for article (PubMed ID: 1915241)
1. Analysis of cerebrospinal fluid from patients with psychiatric and neurological disorders by two-dimensional electrophoresis: identification of disease-associated polypeptides as fibrin fragments.
Wildenauer DB; Körschenhausen D; Hoechtlen W; Ackenheil M; Kehl M; Lottspeich F
Electrophoresis; 1991; 12(7-8):487-92. PubMed ID: 1915241
[TBL] [Abstract][Full Text] [Related]
2. Study of human cerebrospinal fluid proteins by size exclusion-high performance liquid chromatography and two-dimensional gel electrophoresis.
Wiederkehr F; Büeler MR; Wacker M; Vonderschmitt DJ
Electrophoresis; 1989 Jul; 10(7):480-8. PubMed ID: 2776731
[TBL] [Abstract][Full Text] [Related]
3. Horizontal two-dimensional electrophoresis of cerebrospinal fluid proteins with immobilized pH gradients in the first dimension.
Mattila K; Pirttilä T; Frey H
Electrophoresis; 1990 Jan; 11(1):91-2. PubMed ID: 1690646
[TBL] [Abstract][Full Text] [Related]
4. [2-dimensional electrophoresis of cerebrospinal fluid in various neurological patients].
Wiederkehr F; Vonderschmitt DJ
Schweiz Med Wochenschr; 1985 Mar; 115(11):368-73. PubMed ID: 3920755
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia.
Johnson G; Brane D; Block W; van Kammen DP; Gurklis J; Peters JL; Wyatt RJ; Kirch DG; Ghanbari HA; Merril CR
Appl Theor Electrophor; 1992; 3(2):47-53. PubMed ID: 1282367
[TBL] [Abstract][Full Text] [Related]
6. Analysis of immune complexes of cerebrospinal fluid by two-dimensional gel electrophoresis.
Wiederkehr F; Wacker M; Vonderschmitt DJ
Electrophoresis; 1989 Jul; 10(7):473-9. PubMed ID: 2476305
[TBL] [Abstract][Full Text] [Related]
7. 2D DIGE of the cerebrospinal fluid proteome in neurological diseases.
Tumani H; Lehmensiek V; Lehnert S; Otto M; Brettschneider J
Expert Rev Proteomics; 2010 Feb; 7(1):29-38. PubMed ID: 20121474
[TBL] [Abstract][Full Text] [Related]
8. Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry.
Raymackers J; Daniels A; De Brabandere V; Missiaen C; Dauwe M; Verhaert P; Vanmechelen E; Meheus L
Electrophoresis; 2000 Jun; 21(11):2266-83. PubMed ID: 10892737
[TBL] [Abstract][Full Text] [Related]
9. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry.
Davidsson P; Folkesson S; Christiansson M; Lindbjer M; Dellheden B; Blennow K; Westman-Brinkmalm A
Rapid Commun Mass Spectrom; 2002; 16(22):2083-8. PubMed ID: 12415540
[TBL] [Abstract][Full Text] [Related]
10. [Electrophoretic studies of cerebrospinal fluid proteins in neurological diseases with special consideration of liqour proteins in multiple sclerosis].
Arko K
Neuropsihijatrija; 1967; 15(1):73-85. PubMed ID: 5191806
[No Abstract] [Full Text] [Related]
11. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
Jiang L; Lindpaintner K; Li HF; Gu NF; Langen H; He L; Fountoulakis M
Amino Acids; 2003 Jul; 25(1):49-57. PubMed ID: 12836058
[TBL] [Abstract][Full Text] [Related]
12. Two-dimensional polyacrylamide gel electrophoresis of serum and cerebrospinal fluid proteins in multiple sclerosis and subacute sclerosing panencephalitis.
Dams E
Acta Neurol Belg; 1986; 86(4):233-42. PubMed ID: 3766112
[TBL] [Abstract][Full Text] [Related]
13. [Fibrin(ogen degradation product concentration (SFP) as a diagnostic parameter for the differentiation of artifical and essential blood in cerebrospinal fluid].
Hindersin P; Heidrich R
Psychiatr Neurol Med Psychol (Leipz); 1978 Jan; 30(1):36-9. PubMed ID: 643973
[TBL] [Abstract][Full Text] [Related]
14. Identification of a brain-specific human cerebrospinal fluid glycoprotein, beta-trace protein.
Harrington MG; Aebersold R; Martin BM; Merril CR; Hood L
Appl Theor Electrophor; 1993; 3(5):229-34. PubMed ID: 7692978
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.
Maxeiner HG; Rojewski MT; Schmitt A; Tumani H; Bechter K; Schmitt M
Brain Behav Immun; 2009 Jan; 23(1):134-42. PubMed ID: 18771722
[TBL] [Abstract][Full Text] [Related]
16. Existence of deamidated alphaB-crystallin fragments in normal and cataractous human lenses.
Srivastava OP; Srivastava K
Mol Vis; 2003 Apr; 9():110-8. PubMed ID: 12707643
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach.
Sinha A; Srivastava N; Singh S; Singh AK; Bhushan S; Shukla R; Singh MP
Clin Chim Acta; 2009 Feb; 400(1-2):14-20. PubMed ID: 18977210
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry.
Stoop MP; Dekker LJ; Titulaer MK; Burgers PC; Sillevis Smitt PA; Luider TM; Hintzen RQ
Proteomics; 2008 Apr; 8(8):1576-85. PubMed ID: 18351689
[TBL] [Abstract][Full Text] [Related]
19. [Electrophoresis of cerebrospinal fluid proteins].
Schuller E
Nouv Presse Med; 1979 Mar; 8(10):785. PubMed ID: 461129
[No Abstract] [Full Text] [Related]
20. Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis.
D'Aguanno S; Barassi A; Lupisella S; d'eril GM; Del Boccio P; Pieragostino D; Pallotti F; Carelli V; Valentino ML; Liguori R; Avoni P; Bernardini S; Gambi D; Urbani A; Federici G
J Neuroimmunol; 2008 Jan; 193(1-2):156-60. PubMed ID: 18061280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
